# ‘Godzilla’ of weight-loss drugs could provide other important health benefits

> **Newsylist Open Intelligence Dossier** · First detected: 2026-09-30 01:29 UTC · Category: Business · Sources: 1 · Current Velocity: 0.25

## Key People, Organizations & Locations
Godzilla

## Multi-Source Evidence Table
| Source Outlet | Headline | Published (UTC) | Verification URL |
|---|---|---|---|
| Eli Lilly | Lilly's triple agonist, retatrutide, delivered substantial weight loss and A1C reduction, underscoring its potential promise for people with obesity and type 2 diabetes | 2026-09-29 22:01 | [Source Link](https://news.google.com/rss/articles/CBMiwgFBVV95cUxQZVEybVR5TEhfdXpyS29qaVM3RVBvcGY4eU1UcjdRRDJKTkRjV2F0S3p6UDFBLUVrc1J1REtGU25Tc0QzVkVydTdSZ1IyWHRCWDRBZjM5X0o1d21xSkpyQWJvWHhDNlYzMThBdlpsYkZWT1pVTUpEeTdJMDlVdm12em1QdUZXX2NIU3J0dU52QUhNNl9kOGkzc3ZMbTJXNXlfX3JybFhUZnNneTdQbnlUM0pzRWFwRlZ1OXBwc29ZR2Fldw?oc=5) |

---
*Canonical Source: https://www.newsylist.com/trend/2026-09-30/godzilla-of-weight-loss-drugs-could-provide-other-important-health-benefits*
*Synthesized by Newsylist Open Intelligence Engine under E-E-A-T journalistic standards.*